Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-1910-5p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 474, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
SRCAP hsa-miR-1910-5p low: 0 high: 12 2 2 2 -
High-throughput experiments (12 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:30729041-30729068 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr16:30729041-30729068 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30729041-30729068 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr16:30729041-30729068 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr16:30729041-30729068 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:30737137-30737164 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30737137-30737164 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30729041-30729068 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30729041-30729068 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30729041-30729068 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30729041-30729068 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:30729041-30729068 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUCKS1 hsa-miR-1910-5p low: 0 high: 7 1 1 1 0.731
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:205713427-205713446 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:205713427-205713446 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr1:205713427-205713446 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:205713427-205713446 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:205713427-205713446 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:205713427-205713446 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:205713427-205713446 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF281 hsa-miR-1910-5p low: 0 high: 6 2 2 2 0.526
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:200408634-200408653 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:200409096-200409114 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:200409096-200409114 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:200409096-200409114 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:200409096-200409114 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:200409096-200409114 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HSPA1B hsa-miR-1910-5p low: 0 high: 6 1 1 1 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr6:31829904-31829917 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:31829904-31829917 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:31827857-31827875 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:31827857-31827875 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:31827857-31827875 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:31827857-31827875 HITS-CLIP POSITIVE DIRECT TarBase 7.0
LRRC1 hsa-miR-1910-5p low: 0 high: 5 2 2 2 0.691
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:53922718-53922737 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr6:53922718-53922737 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr6:53922718-53922737 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr6:53922718-53922737 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:53922718-53922737 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CEP350 hsa-miR-1910-5p low: 0 high: 4 1 1 1 0.552
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr1:180112892-180112912 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:180112892-180112912 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:180112892-180112912 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:180112892-180112912 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KAZN hsa-miR-1910-5p low: 0 high: 4 1 1 1 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:15066209-15066216 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:15066209-15066216 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:15066209-15066216 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:15066209-15066216 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TNPO2 hsa-miR-1910-5p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr19:12699870-12699890 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:12699870-12699890 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr19:12699373-12699383 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ATL2 hsa-miR-1910-5p low: 0 high: 3 2 2 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:38298303-38298313 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr2:38298298-38298313 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr2:38298298-38298313 HITS-CLIP POSITIVE DIRECT TarBase 7.0
XPO1 hsa-miR-1910-5p low: 0 high: 3 2 2 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:61537984-61538005 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:61478338-61478353 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr2:61537984-61538005 HITS-CLIP POSITIVE DIRECT TarBase 7.0
LARP1 hsa-miR-1910-5p low: 0 high: 3 1 1 1 0.512
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:154815836-154815858 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr5:154815818-154815843 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr5:154815092-154815116 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HIF1AN hsa-miR-1910-5p low: 0 high: 3 1 1 1 0.644
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr10:100548229-100548251 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr10:100548229-100548251 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr10:100548229-100548251 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CDC27 hsa-miR-1910-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:47120738-47120757 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:47120738-47120757 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TNC hsa-miR-1910-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr9:115086430-115086452 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr9:115086430-115086452 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MTMR1 hsa-miR-1910-5p low: 0 high: 2 2 2 2 0.584
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chrX:150764535-150764562 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chrX:150764525-150764542 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ASB1 hsa-miR-1910-5p low: 0 high: 2 1 1 1 0.552
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:238450738-238450761 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr2:238448848-238448864 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KPNB1 hsa-miR-1910-5p low: 0 high: 2 2 2 2 0.463
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:47682769-47682790 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:47682769-47682790 HITS-CLIP POSITIVE DIRECT TarBase 7.0
C11orf58 hsa-miR-1910-5p low: 0 high: 2 2 2 2 0.747
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:16755151-16755169 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr11:16755151-16755169 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ASCC3 hsa-miR-1910-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:100766605-100766633 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:100766605-100766633 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NCL hsa-miR-1910-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr2:231455013-231455041 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr2:231455013-231455041 HITS-CLIP POSITIVE DIRECT TarBase 7.0